Delivery Order SPE2DB22D3501-SPE2DB24FVA49
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $7,155.61 firm fixed price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,741.62 firm-fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,120.20, is a delivery order for the supply of Ozempic 0.25-0.5 mg/dose pens. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at $14,682.57. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a prescription medication used to treat type 2 diabetes. The contract is a firm fixed-price, non-set-aside award with a period of performance through November 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $1,741.62 firm fixed price order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,495.98 firm fixed price delivery order is for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3 mL. Amerisourcebergen Drug Corp is the prime contractor and this award does not have a set-aside designation. This delivery order is one of many awards issued to Amerisourcebergen Drug Corp by DLA to provide...
- This federal contract award is a delivery order worth $1,749.07 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Ozempic 0.25-0.5 mg/dose pens. The contract was awarded by the Defense Logistics Agency (DLA) on March 22, 2024 and has a firm fixed price with a completion date of March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $48,778.06 firm fixed price delivery order is for the pharmaceutical product Ozempic (0.25-0.5 mg/dose pen, 3 mL) to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which...
- This federal contract award to Amerisourcebergen Drug Corp is a $9,169.39 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a specialty pharmaceutical used for diabetes management. The delivery order does not have a set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $19,200.38 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 ml, a prescription medication. The contract has an ultimate completion date of August 7, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVA49Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,161.08 firm fixed price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens, a brand name prescription medication. Amerisourcebergen Drug Corp is the prime contractor and this award is part of a larger $999,999,999.00 indefinite delivery contract (IDC) it holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, valued at up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/25/24 |